Volc, D.; Thun-Hohenstein, C.; Schmidhuber, S.; Mandler, M.; Schneeberger, A.
A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson’s Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response. Vaccines 2026, 14, 466.
https://doi.org/10.3390/vaccines14060466
AMA Style
Volc D, Thun-Hohenstein C, Schmidhuber S, Mandler M, Schneeberger A.
A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson’s Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response. Vaccines. 2026; 14(6):466.
https://doi.org/10.3390/vaccines14060466
Chicago/Turabian Style
Volc, Dieter, Caroline Thun-Hohenstein, Sabine Schmidhuber, Markus Mandler, and Achim Schneeberger.
2026. "A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson’s Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response" Vaccines 14, no. 6: 466.
https://doi.org/10.3390/vaccines14060466
APA Style
Volc, D., Thun-Hohenstein, C., Schmidhuber, S., Mandler, M., & Schneeberger, A.
(2026). A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson’s Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response. Vaccines, 14(6), 466.
https://doi.org/10.3390/vaccines14060466
